Companies: 10,795·Total market cap: $144.5T
Cellebrite DI Ltd.

Cellebrite DI Ltd.

CLBTNASDAQTechnology● Active
$13.43
$-0.38(-2.75%)
Market Cap$3.3B
P/E Ratio
52W High$19.98
52W Low$11.02

Cellebrite DI Ltd. (CLBT) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

clbt · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 8 Wall Street analysts in the past 3 months

SellBuy

Buy

8 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
0
Sell
0
Strong Sell
0
Total: 8 · Buy rate: 100.0%

12-Month Price Target

High

$23.00

Consensus

$19.75

+48.8% upside

Low

$15.00

Median: $20.5 · Last Close: $13.28

The Cellebrite DI Ltd. (CLBT) analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month CLBT price target is $19.75, representing +48.8% upside from the current price of $13.28.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $20 (48.8%)

Consensus Target

$19.75

48.8% upside

High Target

$23

73.3%

Low Target

$15

13.0%

Current Price

$13.28

as of today

Based on analyst price targets, the CLBT stock price prediction for the next 12 months ranges from $15 to $23. The consensus CLBT price forecast of $19.75 implies 48.8% upside from the current price of $13.28.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$13.672.97%

1-day model range: $13.57–$13.77. Peak: $13.77 (+2.97%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$17+26.2%
2028$19+45.9%
2029$21+59.7%
2030$22+68.7%
2031+74.4%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)47.4Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · CLBT · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$14.11SELL
MA 10$13.99SELL
MA 20$13.54SELL
MA 50$13.27BUY
MA 100$13.97SELL
MA 200$15.86SELL
Current $CLBT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$13.89SELL
EMA 10$13.91SELL
EMA 20$13.72SELL
EMA 50$13.65SELL
EMA 100$14.22SELL
EMA 200$15.15SELL
Current $CLBT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Needham2026-05-15
Maintains
BuyBuy
Needham2026-02-12
Maintains
BuyBuy
Lake Street2025-11-13
Maintains
BuyBuy
Needham2025-11-13
Maintains
BuyBuy
B of A Securities2025-11-13
Maintains
BuyBuy
JP Morgan2025-11-13
Maintains
OverweightOverweight
JP Morgan2025-09-24
Maintains
OverweightOverweight
Lake Street2025-08-15
Maintains
BuyBuy
Needham2025-08-14
Maintains
BuyBuy
JP Morgan2025-06-23
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Cellebrite DI Ltd. (CLBT) stock. Of the recent 42 rating actions, 1 were upgrades and 0 were downgrades. 8 analysts currently cover CLBT.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

CLBT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$473M

↓ 29.1% YoY

Revenue Next Year

$568M

↑ 20.1% YoY

EPS This Year

$0.33

EPS Next Year

$0.33

↓ 0.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CLBT EPS of $0.33 for the current fiscal year, based on estimates from 5 analysts. The CLBT revenue forecast is $473M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CLBT stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CLBT price target is $19.75 (+48.8% upside), with an analyst consensus of Buy.

The CLBT short-term stock prediction for tomorrow is $13.67 (+2.97%). The CLBT stock price prediction for 2027 estimates an average of $17. The CLBT stock prediction for 2030 projects a range of $21–$24.

Cellebrite DI Ltd. trades on NASDAQ under the ticker CLBT. The CLBT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CLBT forecast · 8 questions

According to 8 Wall Street analysts, the average 12-month CLBT price target is $19.75, with a high forecast of $23.00 and a low of $15.00. The median price target is shown in the chart above when available. This implies +48.8% potential upside from the current price of $13.28.

CLBT price targetWhat is CLBT price targetCLBT analyst price targetCLBT 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.